Clinical Trials · NCT04873050
Treatment to Regress to Normoglycemia in Women with a Recent History of GDM
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Woman's
- Enrollment
- 102
- Start date
- Jan 2022
- Locations
- 1 site, United States
- Primary endpoint
- Regression to normoglycemia